Impact of fatigue on quality of life among breast cancer patients receiving chemotherapy
10.24171/j.phrp.2021.12.2.09
- Author:
Fares Mohammed SAEED MUTHANNA
1
;
Mahmathi KARUPPANNAN
;
Bassam Abdul RASOOL HASSAN
;
Ali Haider MOHAMMED
Author Information
1. Department of Pharmacy Practice, Faculty of Pharmacy, Universiti Teknologi MARA, Cawangan Selangor, Kampus Puncak Alam, Selangor, Malaysia
- Publication Type:Original Article
- From:
Osong Public Health and Research Perspectives
2021;12(2):115-125
- CountryRepublic of Korea
- Language:English
-
Abstract:
Objectives:Fatigue is the most frequently reported symptom experienced by cancer patients and has a profound effect on their quality of life (QOL). The study aimed to determine the impact of fatigue on QOL among breast cancer patients receiving chemotherapy and to identify the risk factors associated with severe fatigue incidence.
Methods:This was an observational prospective study carried out at multiple centers. In total, 172 breast cancer patients were included. The Functional Assessment of Chronic Illness Therapy-Fatigue Questionnaire was used to measure QOL, while the Brief Fatigue Inventory (BFI) was used to assess the severity of fatigue.
Results:The total average mean and standard deviation of QOL were 84.58±18.07 and 4.65±1.14 for BFI scores, respectively. A significant association between fatigue and QOL was found in linear and multiple regression analyses. The relationships between fatigue severity and cancer stage, chemotherapy dose delay, dose reduction, chemotherapy regimen, and ethnicity were determined using binary logistic regression analysis.
Conclusion:The findings of this study are believed to be useful for helping oncologists effectively evaluate, monitor, and treat fatigue related to QOL changes.
